JW Pharmaceutical

Company

Company Profile

JW Pharmaceutical is a South Korean pharmaceutical company that manufactures medicines and medical supplies across multiple therapeutic areas. The company traces its origin to 1945 and is based in Gwacheon-si, South Korea. It is listed on the Korea Stock Exchange under ticker 001060.

Headquarters
Gwacheon-si, Gyeonggi-do, Republic of Korea
Founded
1945
Stock Ticker
KRX:001060

Related News

Related Clinical Trials

NCT ID Title Status Phase
NCT07523971

Efficacy and Safety of Pitavastatin/Ezetimibe in Dyslipidemia Patients With Metabolic Syndrome: An Observational Study

RECRUITING
NCT07514780

To Evaluate the Safety, Pharmacokinetic and Pharmacodynamics of JW0061 in Healthy Volunteers

RECRUITING PHASE1
NCT07488611

PROGAIN Trial in Gastric Cancer Surgery

RECRUITING PHASE3
NCT07445542

Efficacy and Safety of Pitavastatin/Ezetimibe After Switching From Statin Monotherapy to Pitavastatin/Ezetimibe in Patients With Hypercholesterolemia

COMPLETED
NCT07442630

Long-term Comparison of Pitavastatin/Ezetimibe and Pitavastatin in Patients With Hypercholesterolemia and Elevated Triglycerides

ACTIVE_NOT_RECRUITING PHASE4
NCT07442006

Glycemic Variability of Combination Therapies in T2DM

RECRUITING PHASE4
NCT07382778

Efficacy and Safety of Livalozet® in Hypercholesterolemic Patients With and Without Diabetes

COMPLETED
NCT07378098

to Evaluate the Efficacy and Safety of KLH-2109 in Patients With Uterine Fibroids and Menorrhagia

RECRUITING PHASE3
NCT07374406

To Evaluate the Safety and Pharmacokinetic Characteristics in Healthy Volunteers

COMPLETED PHASE1
NCT07036458

To Evaluate the Mass Balance Recovery, Metabolite Profile and Metabolite Identification in Healthy Male Subjects

COMPLETED PHASE1